Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-28

FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a fixed-dose combination product of amlodipine and olmesartan medoxomil from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)